Final answer:
The DEA requires maintaining records of receipt/invoice for CIII-CV medications to ensure proper documentation and compliance with regulations.
Step-by-step explanation:
For CIII-CV medications, the DEA requires that you maintain a record of receipt/invoice from the supplier. This means that all transactions involving controlled substances scheduled between III and V must be documented appropriately.
Maintaining accurate records of these receipts and invoices is essential for compliance with the DEA's regulations and ensures that there is an auditable trail of the controlled substances from the moment they are received until they are dispensed. For CIII-CV medications, the DEA requires that you maintain a record of receipt/invoice from the supplier. This means that all transactions involving controlled substances scheduled between III and V must be documented appropriately. Maintaining accurate records of these receipts and invoices is essential for compliance with the DEA's regulations and ensures that there is an auditable trail of the controlled substances from the moment they are received until they are dispensed.